Risk scoring for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 3, 2017, Pages

  Karmali, Kunal N ^a   Persell, Stephen D ^b   Perel, Pablo ^c   Lloyd Jones, Donald M ^a   Berendsen, Mark A ^a   Huffman, Mark D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; DECISION SUPPORT SYSTEM; DIASTOLIC BLOOD PRESSURE; DIET; EMBASE; EXERCISE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; MEDICATION COMPLIANCE; MEDLINE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ADULT; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEART DISEASES; META ANALYSIS; PROCEDURES; RISK ASSESSMENT; STROKE;

ADULT; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; HEART DISEASES; HUMANS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 85015034890     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006887.pub4     Document Type: Review

References (221)

1. Benner JS, Cherry SB, Erhardt L, Fernandes M, Flammer M, Gaciong Z, et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials 2007;28:662-73. 5307360
2. Benner JS, Erhardt L, Flammer M, Moller RA, Rajicic N, Changela K, et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice 2008;62:1484-98. 5307361
3. Bertoni AG, Bonds DE, Chen H, Hogan P, Crago L, Rosenberger E, et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine 2009;169:678-86. 5307363
4. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice 1994;44:62-7. 5307365
5. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308:313-20. 5307366
6. Bucher HC, Rickenbach M, Young J, Glass TR, Vallet Y, Bernasconi E, et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy 2010;15(1):31-40. 5307368
7. Christensen B, Engberg M, Lauritzen T. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation 2004;11(3):239-43. 5307370
8. Cobos A, Vilaseca J, Asenjo C, Pedro-Botet J, Sanchez E, Val A, et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes 2005;13(6):421-32. 5307372
9. Denig P, Dun M, Schuling J, Haaijer-Ruskamp FM, Voorham J. The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials 2012;13:219. 5307374
10. Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ 2014;349:g5651. 5307375
11. Eaton CB, Parker DR, Borkan J, McMurray J, Roberts MB, Lu B, et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine 2011;9(6):528-37. 5307377
12. Edelman D, Oddone EZ, Liebowitz RS, Yancy WS Jr, Olsen MK, Jeffreys AS, et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine 2006;21(7):728-34. 5307379
13. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger 2002;164:3354-60. 5307381
14. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice 2002;51:546-52. 5307382
15. Lauritzen T, Leboeuf-Yde C, Lunde IM, Nielsen KD. Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice 1995;45:542-7. 5307383
16. Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine 2009;24:33-9. 5307385
17. Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine 2007;167:2296-303. 5307386
18. Hall LM, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 2003;326:251-2. 5307388
19. Hanlon P, McEwen J, Carey L, Gilmour H, Tannahill C, Tannahill A, et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ 1995;311:1609-13. 5307390
20. Hanon O, Franconi G, Mourad JJ, Baleydier A, Croce I, Girerd X. The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux 2000;93(8):943-7. 5307392
21. Hetlevik I, Holmen J, Kruger O. Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care 1999;17:35-40. 5307394
22. Holt TA, Thorogood M, Griffiths F, Munday S. Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials 2006;7:11. 5307397
23. Holt TA, Thorogood M, Griffiths F, Munday S, Friede T, Stables D. Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice 2010;60:e137-43. 5307396
24. Jacobson TA, Gutkin SW, Harper CR. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion 2006;22:1065-73. 5307399
25. Baumann S, Toft U, Aadahl M, Jorgensen T, Pisinger C. The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity 2015;12:33. 5307401
26. Jorgensen T, Jacobsen RK, Toft U, Aadahl M, Glumer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348:g3617. 5307402
27. Jorgensen T, Ladelund S, Borch-Johnsen K, Pisinger C, Schrader AM, Thomsen T, et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine 2009;48:242-6. 5307403
28. Pisinger C, Glumer C, Toft U, von Huth Smith L, Aadahl M, Borch-Johnsen K, et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine 2008;46(6):579-84. 5307404
29. Toft U, Kristoffersen L, Ladelund S, Ovesen L, Lau C, Borch-Johnsen K, et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine 2008;47(4):378-83. 5307405
30. Von Huth Smith L, Ladelund S, Borch-Johnsen K, Jorgensen T. A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health 2008;36(4):380-8. 5307406
31. Koelewijn-van Loon MS, van Steenkiste B, Ronda G, Wensing M, Stoffers HE, Elwyn G, et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research 2008;8:9. 5307408
32. Koelewijn-van Loon MS, van der Weijden T, Ronda G, van Steenkiste B, Winkens B, Elwyn G, et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine 2010;50(1-2):35-44. 5307409
33. Koelewijn-van Loon MS, van der Weijden T, van Steenkiste B, Ronda G, Winkens B, Severens JL, et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal 2009;181(12):E267-E274. 5307410
34. Keller H, Krones T, Becker A, Hirsch O, Sonnichsen AC, Popert U, et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology 2012;19(3):322-9. 5307412
35. Krones T, Keller H, Sonnichsen A, Sadowski EM, Baum E, Wegscheider K, et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine 2008;6:218-27. 5307413
36. Lopez-Gonzalez AA, Aguilo A, Frontera M, Bennasar-Veny M, Campos I, Vicente-Herrero T, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology 2015;22(3):389-96. 5307415
37. Lowensteyn I, Joseph L, Levinton C, Abrahamowicz M, Steinert Y, Grover S. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine 1998;27(5 Pt 1):730-7. 5307417
38. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling 2010;80:138-140. 5307419
39. Fahey T, Montgomery AA, Peters TJ. Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research 2001;1:10. 5307421
40. Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 2000;320:686-90. 5307422
41. Emmett CL, Montgomery AA, Peters TJ, Fahey T. Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice 2005;55:551-3. 5307424
42. Montgomery AA, Fahey T, Peters TJ. A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice 2003;53:446-53. 5307425
43. Panaretto KS, Peiris D, Usherwood T, Harris M, Hunt J, Patel A. Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?. Circulation 2012;125:e808. 5307427
44. Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Patel B, et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open 2012;2(6):e002177. 5307428
45. Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Redfern J, et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes 2015;8:87-95. 5307429
46. Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Zwar N, et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart 2014;9:e28. 5307430
47. Perestelo-Perez L, Rivero-Santana A, Boronat M, Sanchez-Afonso JA, Perez-Ramos J, Montori VM, et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling 2016;99(2):295-9. 5307432
48. Persell SD, Lloyd-Jones DM, Friesema EM, Cooper AJ, Baker DW. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine 2013;28(4):554-60. 5307434
49. Persell SD, Lloyd-Jones DM, Friesma EM, Cooper AJ, Baker DW. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine 2012;27:S181-2. 5307435
50. Persell SD, Brown T, Lee JY, Shah S, Henley E, Long T, et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes 2015;8(6):560-6. 5307437
51. Persell SD, Shah S, Brown T, Lee JY, Sanchez T, Knight RG, et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation 2014;130:A14008. 5307438
52. Shah S, Brown T, Lee JY, Jean-Jacques M, Kandula NR, Persell SD. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine 2014;29:S126. 5307439
53. Price HC, Griffin SJ, Holman RR. Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine 2011;28(3):363-72. 5307441
54. Price HC, Tucker L, Griffin SJ, Holman RR. The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology 2008;7:21. 5307442
55. Sheridan SL, Shadle J, Simpson RJ Jr, Pignone MP. The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research 2006;6:121. 5307444
56. Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson RJ Jr, Rimer B, et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research 2011;11:331. 5307446
57. Sheridan SL, Draeger LB, Pignone MP, Rimer B, Bangdiwala SI, Cai J, et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making 2014;14:14. 5307447
58. Soureti A, Murray P, Cobain M, van Mechelen W, Hurling R. Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research 2011;13:e100. 5307449
59. Turner BJ, Hollenbeak CS, Liang Y, Pandit K, Joseph S, Weiner MG. A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine 2012;27:1258-64. 5307451
60. Vagholkar S, Zwar N, Jayasinghe UW, Denney-Wilson E, Patel A, Campbell T, et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal 2014;167(1):28-35. 5307453
61. Wan Q, Harris MF, Zwar N, Campbell T, Patel A, Vagholkar S, et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal 2009;157:436-41. 5307454
62. Van Steenkiste B, van der Weijden T, Stoffers HE, Kester AD, Timmermans DR, Grol R. Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation 2007;14:44-50. 5307456
63. Van Steenkiste B, van der Weijden TM, Stoffers JH, Grol RP. Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling 2008;72(1):63-70. 5307457
64. Webster R, Li SCh, Sullivan DR, Jayne K, Su SY, Neal B. Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research 2010;12(3):e42. 5307459
65. Welschen LM, Bot SD, Dekker JM, Timmermans DR, Weijden T, Nijpels G. The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health 2010;10:457. 5307461
66. Welschen LM, Bot SD, Kostense PJ, Dekker JM, Timmermans DR, van der Weijden T, et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care 2012;35:2485-92. 5307462
67. Welschen LMC, Bot SDM, van der Weijden T, Timmermans DRM, Dekker JM, Nijpels G. Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia 2010;53:S487. 5307463
68. Williams GC, McGregor H, Sharp D, Kouides RW, Levesque CS, Ryan RM, et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine 2006;21:1288-94. 5307465
69. Williams GC, Minicucci DS, Kouides RW, Levesque CS, Chirkov VI, Ryan RM, et al. Self-determination, smoking, diet and health. Health Education Research 2002;17(5):512-21. 5307466
70. Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal 2007;177(8):859-65. 5307468
71. Zullig LL, Sanders LL, Shaw RJ, McCant F, Danus S, Bosworth HB. A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare 2014;20:147-52. 5307470
72. Ajay VS, Tian M, Chen H, Wu Y, Li X, Dunzhu D, et al. A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale. BMC Public Health 2014;14:924. 5307472
73. Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, et al. Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circulation: Cardiovascular Quality and Outcomes 2011;4(6):595-602. 5307474
74. Avis NE, Smith KW, McKinlay JB. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed?. American Journal of Public Health 1989;79(12):1608-12. 5307476
75. Baruth M, Wilcox S, Sallis JF, King AC, Marcus BH, Blair SN. Changes in CVD risk factors in the activity counseling trial. International Journal of General Medicine 2011;4:53-62. 5307478
76. Berra K, Ma J, Klieman L, Hyde S, Monti V, Guardado A, et al. Implementing cardiac risk-factor case management: lessons learned in a county health system. Critical Pathways in Cardiology 2007;6:173-9. 5307480
77. Bjarnason-Wehrens B, Albus C, Heming C, Gysan D, Herold G, Latsch J, et al. Can a multimodale intervention improve exercise capacity in patients with high cardiovascular risk on a sustained basis-the PreFord-study. European Journal of Preventive Cardiology 2013;20:S3. 5307482
78. Predel HG, Gysan DB, Albus C, Bjarnason-Wehrens B, Gohlke H, Latsch J, et al. Substantial improvement of primary cardiovascular prevention by a systematic score-based multimodal and lifestyle approach: a randomized endpoint-study-the Preford-study. Circulation 20115;132:A17097. 5307483
79. Black JA, Sharp SJ, Wareham NJ, Sandbaek A, Rutten GE, Lauritzen T, et al. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial. Diabetic Medicine 2014;31:647-656. 5307485
80. Botija-Yague MP, Lizan-Tudela L, Gosalbes-Soler V, Bonet-Pla A, Fornos-Garrigos A. How does intensive therapy to control cardiovascular risk factors affect health-related quality of life in diabetic patients? [¿Cómo influye el trata- miento intensivo de los factores de riesgo cardiovascular en la calidad de vida relacionada con la salud de los pacientes diabéticos?]. Atencion Primaria 2007;39:227-34. 5307487
81. Branda ME, LeBlanc A, Shah ND, Tiedje K, Ruud K, Van Houten H, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Services Research 2013;13:301. 5307489
82. Brett T, Arnold-Reed D, Phan C, Cadden F, Walker W, Manea-Walley W, et al. The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction. British Journal of General Practice 2012;62:e22-8. 5307491
83. Bruckert E, Giral P, Paillard F, Ferrières J, Schlienger JL, Renucci JF, et al. Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patients. Cardiovascular Drugs and Therapy 2008;22:495-505. 5307493
84. Carrington MJ, Schute F, Haluska B, Marwick TH, Holliday J, Stewart S. Preliminary results of the impress study: reducing cardiovascular risk factors in a nurse-led primary intervention program for high risk participants. European Heart Journal 2012;33:1063. 5307495
85. CARRS Trial Writing Group, Shah S, Singh K, Ali MK, Mohan V, Kadir MM, et al. Improving diabetes care: multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia--the CARRS multi-center translation trial. Diabetes Research and Clinical Practice 2012;98(2):285-94. 5307497
86. Carter M, Karwalajtys T, Chambers L, Kaczorowski J, Dolovich L, Gierman T, et al. Implementing a standardized community-based cardiovascular risk assessment program in 20 Ontario communities. Health Promotion International 2009;24(4):325-33. 5307499
87. Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, et al. A cluster-randomized trial of a centralized clinical pharmacy cardiovascular risk service to improve guideline adherence. Pharmacotherapy 2015;35(7):653-62. 5307501
88. Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, et al. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. American Heart Journal 2009;158:349-55. 5307503
89. Claes N, Jacobs N. The PreCardio-study protocol--a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme. BMC Cardiovascular Disorders 2007;7:27. 5307505
90. Cleveringa FG, Gorter KJ, van den Donk M, Rutten GE. Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care 2008;31:2273-5. 5307507
91. Cleveringa FG, Welsing PM, van den Donk M, Gorter KJ, Niessen LW, Rutten GE, et al. Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk. Diabetes Care 2010;33(2):258-63. 5307508
92. Cleveringa FGW, Gorter KJ, van den Donk M, Rutten GEH. Task delegation and computerised decision support improve cardiovascular risk for type 2 diabetes patients. A randomised controlled trial in primary care. Diabetologia 2007;50:S117. 5307509
93. Cochrane T, Davey R, Iqbal Z, Gidlow C, Kumar J, Chambers R, et al. NHS health checks through general practice: randomised trial of population cardiovascular risk reduction. BMC Public Health 2012;12:944. 5307511
94. Colwell B, Mathers N, Bradley A, Ng CJ. Does a PDA improve knowledge about treatment choices for patients with type 2 diabetes mellitus when making decisions about starting insulin? Quantitative analysis from the PANDAs study. Diabetologia 2011;54:S406. 5307513
95. Daniels EC, Powe BD, Metoyer T, McCray G, Baltrus P, Rust GS. Increasing knowledge of cardiovascular risk factors among African Americans by use of community health workers: the ABCD community intervention pilot project. Journal of the National Medical Association 2012;104(3-4):179-85. 5307515
96. Deales A, Fratini M, Romano S, Rappelli A, Penco M, Perna GP, et al. Care manager to control cardiovascular risk factors in primary care: the Raffaello cluster randomized trial. Nutrition, Metabolism & Cardiovascular Diseases 2014;24:563-71. 5307517
97. Romano S, Rappelli A, Musilli A, Perna G, Fratini M, Manzoli L, et al. Project Raffaello: Application and evaluation of the disease and care management approach in cardiovascular disease prevention. European Heart Journal 2011;32:219. 5307518
98. Dresser GK, Moor R, Khan R, Khanna R, Har BJ. Compliance with prescribed therapy and patient perceptions in the treatment of hypertension. Journal of Clinical Hypertension 2009;11:A57. 5307520
99. Edwards A, Thomas R, Williams R, Ellner AL, Brown P, Elwyn G. Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial. Patient Education and Counseling 2006;63:336-49. 5307522
100. El Fakiri F, Bruijnzeels MA, Uitewaal PJ, Frenken RA, Berg M, Hoes AW. Intensified preventive care to reduce cardiovascular risk in healthcare centres located in deprived neighbourhoods: a randomized controlled trial. European Journal of Cardiovascular Prevention and Rehabilitation 2008;15:488-93. 5307524
101. Evans CD, Eurich DT, Taylor JG, Blackburn DF. The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study. Pharmacotherapy 2010;30(8):766-75. 5307526
102. Fàbregas M, Berges I, Fina F, Hermosilla E, Coma E, Méndez L, et al. Effectiveness of an intervention designed to optimize statins use: a primary prevention randomized clinical trial. BMC Family Practice 2014;15:135. 5307528
103. Fretheim A, Oxman AD, Havelsrud K, Treweek S, Kristoffersen DT, Bjorndal A. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLOS Medicine 2006;3(6):e134. 5307530
104. Fretheim A, Oxman AD, Treweek S, Bjorndal A. Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]. BMC Health Services Research 2003;3:5. 5307531
105. Freund N, Friedli BC, Junker T, Zimmermann M, Zellweger MJ. Cardiovascular risk assessment and effects on behavior in Switzerland: the Swiss Heart Foundation HerzCheck(R)/Cardio-Test(R). Open Cardiovascular Medicine Journal 2015;9:35-9. 5307533
106. Gill JM, Chen YX, Glutting JJ, Diamond JJ, Lieberman MI. Impact of decision support in electronic medical records on lipid management in primary care. Population Health Management 2009;12(5):221-6. 5307535
107. Gomez-Marcos MA, Ortiz LG, Gonzalez-Elena LJ, Rodriguez AS. Effectiveness of an intervention to improve quality care in reducing cardiovascular risk in hypertensive patients [Efectividad de una intervención de mejora de calidad en la reducción del riesgo coronario y del riesgo de mortalidad cardiovascular en pacientes hipertensos]. Atencion Primaria 2006;37:498-503. 5307537
108. Green BB, Anderson ML, Cook AJ, Catz S, Fishman PA, McClure JB, et al. e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk. American Journal of Preventive Medicine 2014;46(4):368-77. 5307539
109. Harmsen CG, Jarbøl DE, Nexøe J, Støvring H, Gyrd-Hansen D, Nielsen JB, et al. Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT) cluster-randomised trial in general practice. BMC Health Services Research 2013;13:76. 5307541
110. Harmsen CG, Kristiansen IS, Larsen PV, Nexoe J, Stovring H, Gyrd-Hansen D, et al. Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. The British Journal of General Practice 2014;64(621):e199-207. 5307542
111. Holbrook A, Pullenayegum E, Thabane L, Troyan S, Foster G, Keshavjee K, et al. Shared electronic vascular risk decision support in primary care: Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III) randomized trial. Archives of Internal Medicine 2011;171(19):1736-44. 5307544
112. Hormigo-Pozo A, Viciana-Lopez MA, Gomez-Jimenez L, Gallego-Parrilla MD, Orellana-Lozano J, Morales-Asencio JM. Improved effectiveness in the management of cardiovascular risk among type 2 diabetic patients in primary health care [Mejora de la efectividad en el manejo del riesgo cardiovascular de pacientes diabéticos tipo 2 en atención primaria]. Atencion Primaria 2009;41:240-5. 5307546
113. Huntink E, Heijmans N, Wensing M, van Lieshout J. Effectiveness of a tailored intervention to improve cardiovascular risk management in primary care: study protocol for a randomised controlled trial. Trials 2013;14(1):433. 5307548
114. Ishani A, Greer N, Taylor BC, Kubes L, Cole P, Atwood M, et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes: a randomized controlled trial. Diabetes Care 2011;34:1689-94. 5307550
115. Jacobs N, Drost R, Ament A, Evers S, Claes N. Willingness to pay for a cardiovascular prevention program in highly educated adults: a randomized controlled trial. International Journal of Technology Assessment in Health Care 2011;27(4):283-9. 5307552
116. Jennings C, Wood D. EUROACTION: a family-based preventive cardiology programme in primary care. Practical Cardiovascular Risk Management 2006;4:12-15. 5307554
117. Jones LA, Weymiller AJ, Shah N, Bryant SC, Christianson TJ, Guyatt GH, et al. Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. Medical Decision Making 2009;29:468-74. 5307556
118. Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011;342:d442. 5307558
119. Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, McDonough B, et al. Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Preventive Medicine 2008;46(6):537-44. 5307559
120. Kaczorowski JA, Chambers LW, Dolovich L, Farrell B, McDonough B, Sebaldt R, et al. Improving cardiovascular health at the population level: a 39 community cluster randomized trial of the Cardiovascular Health Awareness Program (C-CHAP). Stroke 2010;41:e474. 5307560
121. Ketola E, Mäkelä M, Klockars M. Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care. British Journal of General Practice 2001;51:291-4. 5307562
122. Keyserling TC, Sheridan SL, Draeger LB, Finkelstein EA, Gizlice Z, Kruger E, et al. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Internal Medicine 2014;174(7):1144-57. 5307564
123. Sheridan SL, Draeger LB, Pignone MP, Sloane PD, Samuel-Hodge C, Finkelstein EA, et al. Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemporary Clinical Trials 2013;36(2):394-405. 5307565
124. Sheridan SL, Keyserling TC, Draeger LB. A randomized trial of a web-based versus counselor based intervention to reduce CHD risk. Journal of General Internal Medicine 2013;28:S13. 5307566
125. Brown SA, Jouni H, Austin E, Marroush T, Kullo I. Effect of disclosure of genetic risk for coronary heart disease on information seeking and information sharing in a randomized clinical trial (from the MI-GENES Investigators). Circulation 2015;132:A16508. 5307568
126. Kullo IJ, Jouni H, Austin EE, Brown SA, Kruisselbrink TM, Isseh IN, et al. Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial). Circulation 2016;133(12):1181-8. 5307569
127. Kullo IJ, Jouni H, Olson JE, Montori VM, Bailey KR. Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study. BMC Medical Genomics 2015;8:51. 5307570
128. Robinson CL, Jouni H, Kruisselbrink TM, Austin EE, Christensen KD, Green RC, et al. Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. Clinical Genetics 2016;89(2):251-7. 5307571
129. Robinson CL, Jouni H, Kruisselbrink TM, Christensen KD, Green RC, Kullo IJ. The effect of disclosing genetic risk for coronary heart disease on perceived personal control and genetic counseling satisfaction: the MI-genes study. Circulation 2014;130:A20188. 5307572
130. Laan EK, Kraaijenhagen RA, Peek N, Busschers WB, Deutekom M, Bossuyt PM, et al. Effectiveness of a web-based health risk assessment with individually-tailored feedback on lifestyle behaviour: study protocol. BMC Public Health 2012;12:200. 5307574
131. Lalonde L, O'Connor AM, Drake E, Duguay P, Lowensteyn I, Grover SA. Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease. Pharmacotherapy 2004;24:909-22. 5307576
132. Lalonde L, O'Connor AM, Duguay P, Brassard J, Drake E, Grover SA. Evaluation of a decision aid and a personal risk profile in community pharmacy for patients considering options to improve cardiovascular health: the OPTIONS pilot study. International Journal of Pharmacy Practice 2006;14:51-62. 5307578
133. Lauritzen T, Jensen MS, Thomsen JL, Christensen B, Engberg M. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health 2008;36(6):650-61. 5307580
134. Liddy C, Hogg W, Russell G, Wells G, Armstrong CD, Akbari A, et al. Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care. Implementation Science 2011;6(1):110. 5307582
135. Liddy C, Hogg W, Singh J, Taljaard M, Russell G, Deri Armstrong C, et al. A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care. Implementation Science 2015;10:150. 5307583
136. Lindholm LH, Ekbom T, Dash C, Eriksson M, Tibblin G, Scherstén B. The impact of health care advice given in primary care on cardiovascular risk. BMJ 1995;310:1105-9. 5307585
137. Ma J, Berra K, Haskell WL, Klieman L, Hyde S, Smith MW, et al. Case management to reduce risk of cardiovascular disease in a county health care system. Archives of Internal Medicine 2009;169(21):1988-95. 5307587
138. Mendis S, Johnston SC, Fan W, Oladapo O, Cameron A, Faramawi MF. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bulletin of the World Health Organization 2010;88(6):412-9. 5307589
139. Mills M, Loney P, Jamieson E, Gafni A, Browne G, Bell B, et al. A primary care cardiovascular risk reduction clinic in Canada was more effective and no more expensive than usual on-demand primary care--a randomised controlled trial. Health & Social Care in the Community 2010;18:30-40. 5307591
140. Mortsiefer A, Meysen T, Schumacher M, Abholz HH, Wegscheider K, In der Schmitten J. From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial. BMC Family Practice 2015;16:56. 5307593
141. NCT01134458 . Personalized cardiovascular risk information to initiate and maintain health behavior changes (FIMDM_CVD) [Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes]. clinicaltrials.gov/ct2/show/NCT01134458 (first received 28 May 2010). 5307595
142. NCT01979471 . The Alberta vascular risk reduction community pharmacy project: RxEACH (RxEACH) [The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH]. clinicaltrials.gov/ct2/show/NCT01979471 (first received 1 November 2013). 5307597
143. Nebieridze D, Safarian AS, Shalnova SA, Deev AD, Oganov RG. The efficacy of integration in clinical practice of electronic version of SCORE in treating hypertensive patients. European Journal of Cardiovascular Prevention and Rehabilitation 2011;18:S81. 5307599
144. Paterson JM, Llewellyn-Thomas HA, Naylor CD. Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk. Health Expectations 2002;5(1):3-15. 5307601
145. Pignone M, Sheridan SL, Lee YZ, Kuo J, Phillips C, Mulrow C, et al. Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention. Preventive Cardiology 2004;7(1):26-33. 5307603
146. Powers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication. American Heart Journal 2011;161(4):673-80. 5307605
147. Qureshi N, Armstrong S, Dhiman P, Saukko P, Middlemass J, Evans PH, et al. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Annals of Internal Medicine 2012;156(4):253-62. 5307607
148. Reid C, McNeil JJ, Williams F, Powles J. Cardiovascular risk reduction: a randomized trial of two health promotion strategies for lowering risk in a community with low socioeconomic status. Journal of Cardiovascular Risk 1995;2:155-63. 5307609
149. Rodriguez-Salceda I, Escortell-Mayor E, Rico-Blazquez M, Riesgo-Fuertes R, Asunsolo-del Barco A, Valdivia-Perez A, et al. EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting. BMC Public Health 2010;10:449. 5307611
150. Selvaraj FJ, Mohamed M, Omar K, Nanthan S, Kusiar Z, Subramaniam SY, et al. The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (the DISSEMINATE Study): a randomised controlled trial. BMC Family Practice 2012;13:97. 5307613
151. Sheridan SL, Draeger LB, Pignone M, Keyserling TC. Patients' choices for lifestyle change versus medication use to reduce elevated CVD risk. Journal of General Internal Medicine 2012;27:S268. 5307615
152. Skinner TC, Barrett M, Greenfield C. Impact of providing people with type 2 diabetes with their actual risk for five diabetes complications: A pilot study. Diabetologia 2011;54:S405-S406. 5307617
153. Smith SA, Shah ND, Bryant SC, Christianson TJH, Bjornsen SS, Giesler PD, et al. Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. Mayo Clinic Proceedings 2008;83:747-57. 5307619
154. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. European Journal of Cardiovascular Prevention and Rehabilitation 2010;17:519-23. 5307621
155. Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens NP, Amerena J, et al. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ 2012;345:e7156. 5307623
156. Stewart S, Carrington MJ, Swemmer CH, Kurstjens NP, Jennings GJ. A national, multicentre, randomized controlled trial of the efficacy of structured care algorithm in achieving individual blood pressure targets at 26 weeks in primary care. European Heart Journal 2012;33:679. 5307624
157. Stewart S, Carrington MJ, Swemmer CH, Kurstjens NP, Jennings GJ. Reduced blood pressure and risk of future cardiovascular disease from structured care algorithm in primary care patients with persistent hypertension: a multicentere randomized controlled trial. European Heart Journal 2012;33:811. 5307625
158. Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. Journal of Cardiovascular Risk 2001;8(5):291-7. 5307627
159. Vaidya R, Pandya KV, Denney-Wilson E, Harris M. Sustaining cardiovascular absolute risk management in Australian general practice. Australian Journal of Primary Health 2012;18(4):304-7. 5307629
160. Van Breukelen-van der Stoep DF, Zijlmans J, Van Zeben D, van der Meulen N, Klop B, de Vries MA, et al. Self-reported adherence to cardiovascular risk reduction intervention of patients with rheumatoid arthritis: results of the Francis study. Atherosclerosis 2014;235:e272. 5307631
161. Van den Brekel-Dijkstra K, Rengers AH, Niessen MA, de Wit NJ, Kraaijenhagen RA. Personalized prevention approach with use of a web-based cardiovascular risk assessment with tailored lifestyle follow-up in primary care practice - a pilot study. European Journal of Preventive Cardiology 2016;23(5):544-51. 5307633
162. Van Limpt PM, Harting J, van Assema P, Ruland E, Kester A, Gorgels T, et al. Effects of a brief cardiovascular prevention program by a health advisor in primary care; the 'Hartslag Limburg' project, a cluster randomized trial. Preventive Medicine 2011;53(6):395-401. 5307635
163. Waldron CA, Gallacher J, van der Weijden T, Newcombe R, Elwyn G. The effect of different cardiovascular risk presentation formats on intentions, understanding and emotional affect: a randomised controlled trial using a web-based risk formatter (protocol). BMC Medical Informatics and Decision Making 2010;10:41. 5307637
164. Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Archives of Internal Medicine 2007;167(10):1076-82. 5307639
165. Zamora A, Fernández de Bobadilla F, Carrion C, Vázquez G, Paluzie G, Elosua R, et al. Pilot study to validate a computer-based clinical decision support system for dyslipidemia treatment (HTE-DLP). Atherosclerosis 2013;231:401-4. 5307641
166. Zamora A, Carrion C, Vazquez G, Martin-Urda A, Vilaseca M, Paluzie G, et al. A clinical decision support system can improves the quality of lipid-lowering therapy in coronary patients. European Heart Journal 2015;36:285-86. 5307643
167. Zhu B, Haruyama Y, Muto T, Yamasaki A, Tarumi F. Evaluation of a community intervention program in Japan using Framingham risk score and estimated 10-year coronary heart disease risk as outcome variables: a non-randomized controlled trial. BMC Public Health 2013;13:219. 5307645
168. Adamson R, Sourij H, Ring A, Price HC, Holman RR. Adding value to the experience of attending a diabetes clinic appointment: Provision of personalised 10 year cardiovascular disease (CVD) risk estimates. Diabetic Medicine 2013;30:194. 5307647
169. Gryn S, Har B, Dresser G. Evaluation of the effect of cardiovascular risk assessment on treatment compliance in hypertension. Journal of Clinical Hypertension 2012; Vol. 14. 5307649
170. Roach P, Saha C, Marrero DG. Communicating cardiovascular risk to Latinos with type 2 diabetes using a Spanish language-based multimedia program. Diabetes 2012;61:A88. 5307651
171. Badenbroek IF, Stol DM, Nielen MM, Hollander M, Kraaijenhagen RA, de Wit GA, et al. Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Family Practice 2014;15:90. 5307653
172. De Koning HJ, van der Aalst CM, van Aerde MA, Ijkema R, van Bruggen R, Oudkerk M. Design and recruitment of the ROBINSCA trial: Screening for cardiovascular disease. European Heart Journal 2015;36:985. 5307655
173. Ijkema R, Van Aerde M A, Van Der Aalst C M, Van Ballegooijen M, Oudkerk M, De Koning H J. A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment and coronary artery calcium: The ROBINSCA study. European Journal of Preventive Cardiology 2014;21:S21. 5307656
174. Maindal HT, Stovring H, Sandbaek A. Effectiveness of the population-based Check your health preventive programme conducted in primary care with 4 years follow-up [the CORE trial]: study protocol for a randomised controlled trial. Trials 2014;15:341. 5307658
175. NCT00694239 . Risk assessment and treat compliance in hypertension education trial (RATCHET) [Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension]. clinicaltrials.gov/ct2/show/NCT00694239 (first received 6 June 2008). 5307660
176. NCT02096887 . Effect of patient education on compliance and cardiovascular risk parameters (FAILAKA) [Effect of Patient Awareness and Education on Compliance and Cardiovascular Risk Factor Control]. clinicaltrials.gov/ct2/show/NCT02096887 (First received 24 March 2014). 5307662
177. Ogedegbe G, Plange-Rhule J, Gyamfi J, Chaplin W, Ntim M, Apusiga K, et al. A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol. Implementation Science 2014;9:73. 5307664
178. Praveen D, Patel A, McMahon S, Prabhakaran D, Clifford GD, Maulik PK, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science 2013;8(1):137. 5307666
179. Redfern J, Usherwood T, Harris MF, Rodgers A, Hayman N, Panaretto K, et al. A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol. BMJ Open 2014;4:e004523. 5307668
180. Sanghavi DM, Conway PH. Paying for Prevention: A Novel Test of Medicare Value-Based Payment for Cardiovasculr Risk Reduction. JAMA 2015;314(2):123-124. 5307670
181. Silarova B, Lucas J, Butterworth AS, Di Angelantonio E, Girling C, Lawrence K, et al. Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour. BMC Public Health 2015;15:868. 5307672
182. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. American Heart Journal 1991;121(1 Pt 2):293-8. [PUBMED: 1985385]
183. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology 2013;29(2):151-67. [PUBMED: 23351925]
184. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002;105(3):310-5. [PUBMED: 11804985]
185. Beswick AD, Brindle P, Fahey T, Ebrahim S. A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PUBMED: 21834196]
186. No authors listed. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995. Journal of the American College of Cardiology 1996;27(5):957-1047. [PUBMED: 8609361]
187. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum, 2011.
188. Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC), Sundström J, Arima H, Woodward M, Jackson R, Karmali K, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014;384(9943):591-8. [PUBMED: 25131978]
189. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92(12):1752-9. [PUBMED: 16621883]
190. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003;24(11):987-1003. [PUBMED: 12788299]
191. Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380(9841):581-90. [PUBMED: 22607822]
192. Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353:i2416. [PUBMED: 27184143]
193. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014;129(25 Suppl 2):S49-73. [PUBMED: 24222018]
194. Grover SA, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ 1995;310(6985):975-8. [PUBMED: 7728035]
195. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6. [PUBMED: 18436948]
196. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes & Endocrinology 2015;3(5):339-55.
197. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
198. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335(7611):136. [PUBMED: 17615182]
199. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336(7659):1475-82. [PUBMED: 18573856]
200. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005;365(9457):434-41. [PUBMED: 15680460]
201. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
202. Meland E, Laerum E, Stensvold I. Assessment of coronary heart disease risk, I. A postal inquiry among primary care physicians. Family Practice 1994;11(2):117-21. [PUBMED: 7958572]
203. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2197-223. [PUBMED: 23245608]
204. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385(9963):117-71.
205. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421. [PUBMED: 12485966]
206. National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).
207. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376(9735):112-23. [PUBMED: 20561675]
208. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal 2016;37(29):2315-81. [PUBMED: 27222591]
209. Pignone M, Phillips CJ, Elasy TA, Fernandez A. Physicians' ability to predict the risk of coronary heart disease. BMC Health Services Research 2003;3(1):13. [PUBMED: 12857356]
210. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
211. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research 2008;8:60. [PUBMED: 18366711]
212. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Archives of Internal Medicine 2010;170(3):230-9. [PUBMED: 20142567]
213. Smith SC Jr, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 2004;109(25):3112-21. [PUBMED: 15226228]
214. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S1-45. [PUBMED: 24222016]
215. Usher-Smith JA, Silarova B, Schuit E, Moons KG, Griffin SJ. Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review. BMJ Open 2015;5(10):e008717.
216. Van der Weijden T, Bos LB, Koelewijn-van Loon MS. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice. Current Opinion in Cardiology 2008;23(5):471-6. [PUBMED: 18670259]
217. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.
218. Willis A, Davies M, Yates T, Khunti K. Primary prevention of cardiovascular disease using validated risk scores: a systematic review. Journal of Royal Society of Medicine 2012;105(8):348-56.
219. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47. [PUBMED: 9603539]
220. Wong SS, Wilczynski NL, Haynes RB. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. Journal of the Medical Library Association 2006;94(1):41-7.
221. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364(9438):937-52. [PUBMED: 15364185]